Press Room
PD-1 Inhibition in Renal Cell Carcinoma
10/29/2014
Brian Rini, MD, comments that researchers are currently developing biomarkers that may help determine whether a disease is susceptible to PD-1 inhibition, potentially aiding clinicians in deciding whether to initiate a checkpoint inhibitor and a TKI in sequence, or concurrently.
Meet Kidney Cancer Survivors!
10/14/2014
Map the locations of survivors nearest you. Join the online conversation on Inspire's new Kidney Cancer Community.
BMS and MD Anderson Cancer Center announce novel research collaboration
10/07/2014
Bristol-Myers Squibb Company (NYSE: BMY) and The University of Texas MD Anderson Cancer Center today announced a novel clinical research collaboration to evaluate multiple immunotherapies...
Nintedanib receives positive CHMP opinion for second-line treatment
09/29/2014
Nintedanib*, when added to docetaxel, is the first lung cancer treatment to have provided over one year overall survival for patients with advanced adenocarcinoma, after first-line chemotherapy.
Surgeon is first in world to use robotic technology to remove kidney tumor in outpatient procedure
09/18/2014
Keck Medical Center of the University of Southern California (USC) is the first medical center in the world to use new robotic technology in an outpatient procedure for a kidney cancer patient.
Scientists unlock hidden potential of cutting-edge cancer drugs
09/17/2014
A class of cutting-edge cancer drugs could keep patients alive for much longer than they do now following a major new discovery about exactly how they attack tumours.
Predictor of kidney cancer death
09/17/2014
The neutrophil-lymphocyte ratio (NLR) is an indicator of the systemic inflammatory response.
Danish kidney cancer patients dying at an alarming rate
09/12/2014
Survival rates much better in neighbouring countries than at home
News Feed| Powered by NeonCRM |